Recombinant Laminin-421 Isolation via Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for isolated laminin-421 for research and therapeutic purposes, as current methods to purify it are unsuccessful in eliminating contaminating laminin chains, hindering studies on its function in cellular differentiation and maintenance.

Innovation Solution

The production of recombinant host cells that express and secrete laminin-421 chains, allowing for the isolation of pure laminin-421 through expression vectors and affinity purification, enabling its use in pharmaceutical compositions and medical devices for cell therapy and tissue repair.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional affinity chromatography is used to purify laminin-421, then some purification is achieved, but contaminating laminin chains (such as laminin β1 chain) remain in the preparation

Engineering Contradiction:
Improvepurification purityVSAvoidcomplete elimination of contaminants
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent segments the laminin molecule into its individual chain components (α4, β2, and γ1 chains) and expresses them separately in recombinant host cells. This allows for the isolation of pure laminin-421 heterotrimers assembled from these specific chains, eliminating contaminating chains like laminin β1 that would be present in conventional mixed-chain preparations.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent extracts and isolates the specific laminin-421 chains from the complex mixture of laminin chains using recombinant expression systems. By taking out only the desired α4, β2, and γ1 chains and assembling them into pure heterotrimers, the method achieves complete separation from contaminating chains while maintaining the functional integrity of laminin-421.

Inventive Principle:
Principle #2Taking out (Extraction)

2Manufacturing precision

If recombinant host cells are used to express laminin-421 chains, then pure laminin-421 can be isolated, but the process complexity increases

Engineering Contradiction:
Improveisolation purityVSAvoidproduction process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs recombinant host cells (such as Chinese hamster ovary cells or other mammalian cell lines) that can be used universally to express multiple laminin chain types. These host cells serve multiple functions: they provide the cellular machinery for protein synthesis, enable post-translational modifications, and allow for scalable production. This universal system simplifies the overall process compared to using different specialized systems for each chain.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent performs preliminary actions by pre-assembling the expression vectors containing the laminin chain cDNAs before introducing them into the host cells. The vectors are designed in advance to include proper promoters, tags, and selection markers, which streamlines the subsequent expression and purification steps. This preliminary preparation reduces the complexity of the overall production process.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The isolation of pure laminin-421 facilitates research on cellular differentiation and therapeutic applications, enhancing cell attachment, proliferation, and migration, improving biocompatibility of medical devices and cell culture devices.

Implementation Method 1

recombinant host cells that express and secrete laminin-421 chains

Methodology Applied
Scientific EffectTranslation:

Implementation Method 2

isolation of pure laminin-421 through expression vectors and affinity purification

Methodology Applied
Scientific EffectAffinity chromatography:

Data Source

PatentUS9534038B2Isolated laminin-421
Publication Date: 2017.01.03 BIOLAMINA

AI summary

The present disclosure provides isolated laminin-421, methods for making recombinant laminin-421, and host cells that express recombinant laminin-421. The present disclosure also provides nucleic acid sequences encoding full length human laminin β2 chain, expression vectors and host cells thereof.